Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial
Open Access
- 26 March 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0214057
Abstract
In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision-making outcomes, in women approaching the age of invitation to mammography screening. Two-stage randomised controlled trial. In the first stage, 40 elementary territorial units of the public healthcare system were selected and randomised to intervention or control. In the second stage, women aged 49-50 years were randomly selected. The target sample size was 400 women. Women in the intervention arm received a decision aid (DA) with detailed information on the benefits and harms of screening. Women in the control arm received a standard leaflet that did not mention harms and recommended accepting the invitation to participate in the Breast Cancer Screening Program (BCSP). The primary outcome was informed choice, defined as adequate knowledge and intentions consistent with attitudes. Secondary outcomes included decisional conflict, worry about breast cancer, time perspective, opinions about the DA or the leaflet, and participation in the BCSP. In the intervention group, 23.2% of 203 women made an informed choice compared to only 0.5% of 197 women in the control group (p < 0.001). Attitudes and intentions were similar in both study groups with a high frequency of women intending to be screened, 82.8% vs 82.2% (p = 0.893). Decisional conflict was significantly lower in the intervention group. No differences were observed in confidence in the decision, anxiety, and participation in BCSP. Women in Spain lack knowledge on the benefits and harms of breast screening. Providing quantitative information on benefits and harms has produced a considerable increase in knowledge and informed choice, with a high acceptance of the informative materials. Trial identifier NCT03046004 at ClinicalTrials.gov registry. Registered on February 4 2017. Trial name: InforMa study.Keywords
Funding Information
- Instituto de Salud Carlos III (PI14/00113)
- U.S. Department of War (PI14/00113)
- IRBLleida (Predoc grant for Anna Pons)
This publication has 33 references indexed in Scilit:
- The benefits and harms of breast cancer screening: an independent reviewBritish Journal of Cancer, 2013
- Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative studyBMJ Open, 2013
- A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trialBMJ, 2010
- Decision-Making Processes for Breast, Colorectal, and Prostate Cancer Screening: The DECISIONS SurveyMedical Decision Making, 2010
- Cancer screening in SpainAnnals of Oncology, 2010
- European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary documentAnnals of Oncology, 2008
- Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: A randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be testedPatient Education and Counseling, 2006
- A measure of informed choiceHealth Expectations, 2001
- The development of a six‐item short‐form of the state scale of the Spielberger State—Trait Anxiety Inventory (STAI)British Journal of Clinical Psychology, 1992
- On Chi-Squared Tests for Multiway Contingency Tables with Cell Proportions Estimated from Survey DataThe Annals of Statistics, 1984